Mersana Therapeutics (NASDAQ:MRSN) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Mersana Therapeutics will report an earnings per share (EPS) of $-0.17.

The market awaits Mersana Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Performance in Previous Earnings

Last quarter the company missed EPS by $0.03, which was followed by a 8.89% drop in...